Evidence map›Paper›PMID 39818952›Full record

ArticleJCO clinical cancer informatics2025

Toward a Computable Phenotype for Determining Eligibility of Lung Cancer Screening Using Electronic Health Records.

Shuang Yang, Yu Huang, Xiwei Lou, Tianchen Lyu, Ruoqi Wei, Hiren J Mehta, Yonghui Wu, Michelle Alvarado, Ramzi G Salloum, Dejana Braithwaite and 4 more

Abstract read
In one paragraph

Article in JCO clinical cancer informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Shuang YangDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL.ORCID 0000-0002-9890-7668
Yu HuangDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL.ORCID 0000-0001-7373-4716
Xiwei LouDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL.
Tianchen LyuDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL.
Ruoqi WeiDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL.ORCID 0009-0005-8752-0360
Hiren J MehtaDivision of Pulmonary, Critical Care, and Sleep Medicine, University of Florida College of Medicine, Gainesville, FL.
Yonghui WuDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL.ORCID 0000-0002-6780-6135
Michelle AlvaradoDepartment of Industrial and Systems Engineering, University of Florida, Gainesville, FL.ORCID 0000-0001-9649-214X
Ramzi G SalloumDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL.ORCID 0000-0002-8139-2418
Dejana BraithwaiteDepartment of Epidemiology, College of Public Health and Health Professions, University of Florida, Gainesville, FL.ORCID 0000-0001-8376-5903
Jinhai HuoWW HEOR-US Markets, Bristol Myers Squibb, Lawrenceville, NJ.
Ya-Chen Tina ShihSection of Cancer Economics and Policy, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0001-7290-3864
Yi GuoDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL.ORCID 0000-0003-0587-4105
Jiang BianDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL.ORCID 0000-0002-2238-5429

Funding

Disparities of Alzheimer's disease progression in Sexual Minority IndividualsR01AG080624 · NIA · UNIVERSITY OF FLORIDA · PI Jiang Bian, Yi Guo · 2023 to 2026
$3.1M
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)R01CA284646 · NCI · UNIVERSITY OF FLORIDA · PI Dejana K Braithwaite, Michael K Gould · 2023 to 2026
$2.1M
The benefits and harms of lung cancer screening in FloridaR01CA246418 · NCI · UNIVERSITY OF FLORIDA · PI BIAN, JIANG, GUO, YI · 2020 to 2023
$1.7M
Using Electronic Health Records from a Large Clinical Data Research Network to Understand Cancer Burden and Cancer Risks Among Transgender and Gender Nonconforming (TGNC) IndividualsR21CA245858 · NCI · UNIVERSITY OF FLORIDA · PI BIAN, JIANG, GUO, YI · 2020 to 2021
$773k
Optimizing the Population Representativeness of Older Adults in Alzheimer's Disease and Related Dementia Clinical TrialsR21AG068717 · NIA · UNIVERSITY OF FLORIDA · PI BIAN, JIANG, GUO, YI · 2020 to 2021
$419k
Optimizing the Population Representativeness of Older Adults in Cancer TrialsR21CA253394 · NCI · UNIVERSITY OF FLORIDA · PI BIAN, JIANG, GUO, YI · 2021 to 2021
$392k
NCCDPHP CDC HHS U18 DP006512NCI NIH HHS R01 CA246418NCI NIH HHS R01 CA284646NCI NIH HHS R21 CA245858NCI NIH HHS R21 CA253394NIA NIH HHS R01 AG080624NIA NIH HHS R21 AG068717
6 · The paper itself

Abstract

purposeLung cancer screening (LCS) has the potential to reduce mortality and detect lung cancer at its early stages, but the high false-positive rate associated with low-dose computed tomography (LDCT) for LCS acts as a barrier to its widespread adoption. This study aims to develop computable phenotype (CP) algorithms on the basis of electronic health records (EHRs) to identify individual's eligibility for LCS, thereby enhancing LCS utilization in real-world settings. MATERIALS AND

methodsThe study cohort included 5,778 individuals who underwent LDCT for LCS from 2012 to 2022, as recorded in the University of Florida Health Integrated Data Repository. CP rules derived from LCS guidelines were used to identify potential candidates, incorporating both structured EHR and clinical notes analyzed via natural language processing. We then conducted manual reviews of 453 randomly selected charts to refine and validate these rules, assessing CP performance using metrics, for example, F1 score, specificity, and sensitivity.

resultsWe developed an optimal CP rule that integrates both structured and unstructured data, adhering to the US Preventive Services Task Force 2013 and 2020 guidelines. This rule focuses on age (55-80 years for 2013 and 50-80 years for 2020), smoking status (current, former, and others), and pack-years (≥30 for 2013 and ≥20 for 2020), achieving F1 scores of 0.75 and 0.84 for the respective guidelines. Including unstructured data improved the F1 score performance by up to 9.2% for 2013 and 12.9% for 2020, compared with using structured data alone.

conclusionOur findings underscore the critical need for improved documentation of smoking information in EHRs, demonstrate the value of artificial intelligence techniques in enhancing CP performance, and confirm the effectiveness of EHR-based CP in identifying LCS-eligible individuals. This supports its potential to aid clinical decision making and optimize patient care.

Indexed as

Early Detection of CancerElectronic Health RecordsEligibility DeterminationLung NeoplasmsAgedAged, 80 and overAlgorithmsFemaleHumansMaleMiddle AgedNatural Language ProcessingPhenotypeTomography, X-Ray Computed

Identifiers

PMID39818952
PMCPMC11748906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.